Alersis Tablets
Over-the-counter medications

Alersis Tablets

Alersis Tablets

Alersis tablets are a systemic antihistamine that works to relieve allergy symptoms. The active substance does not produce a sedative effect. Recommended for allergic rhinitis, urticaria. Has anti-inflammatory effect. Read more about Alersis, dosage and features of the use, read the instructions.

Information

Indications for use (instruction): Alersis Tablets

Elimination of symptoms associated with:

  • allergic rhinitis (sneezing, nasal discharge, itching, swelling and nasal congestion, as well as itching and redness of the eyes, lacrimation, itching of the palate and coughing);
  • urticaria (itching, rash).

How to use

Adults and children 12 years of age: 1 tablet once a day, regardless of food intake, to relieve symptoms associated with allergic rhinitis (including intermittent and persistent allergic rhinitis) and urticaria.

Treatment for intermittent allergic rhinitis occurs before symptoms resolve and can be resumed after symptoms recur (symptoms less than 4 days a week or less than 4 weeks); long-term treatment can be offered to patients during the period of exposure of the allergen.

Children.

The efficacy and safety of Alersis tablets in children under 12 years of age has not been established.

Contraindications

Hypersensitivity to desloratadine or to any of the excipients or to loratadine.

Composition

Active ingredient: desloratadine;

1 tablet contains desloratadine 5 mg.

Excipients: lactose anhydrous, microcrystalline cellulose, calcium anhydrous phosphate, hydroxypropyl cellulose, magnesium stearate, silicon anhydrous colloidal dioxide.

Tablets: hypromellose, titanium dioxide (E 171), talc, indigocarmine (E 132), macrogol 600.

Release form

10 tablets per blister, 1 blister per cardboard pack.

Storage conditions

Store in the original packaging at a temperature not exceeding 25 °C. out of the reach of children.

Manufacturer

Laboratorios Normon SA, Ronda de Valdecarriso, 6, Tres Cantos, 28760 Madrid, Spain.

Sanitary and hygienic conclusion

No.364 dated 05/28/14.

Registration certificate UA/13643/02/01.

Advertising of the drug. Be sure to consult your doctor and read the package leaflet before using this medicine.
be worry

This section of the site contains information about medicines, their properties, methods of use, as well as other specialized information that is intended for healthcare professionals. The information on medicines contained in this section is not a guide for self-diagnosis and / or treatment. LLC SA Pro-Pharma is not responsible for possible negative consequences arising from the independent use of information from this section. Using the information from this section, you do it yourself, understanding that: self-medication can be harmful to your health, you must read the instructions and consult a doctor before using medicines.